Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug,... see more

GREY:ATBPF - Post Discussion

Antibe Therapeutics Inc(Pre-Merger) > Otenaproxesul pulled as Arthritis drug.
View:
Post by MasterAlgae on Oct 14, 2021 8:14am

Otenaproxesul pulled as Arthritis drug.

Repurposed as acute pain drug after surgery.
Not suitable for long-term use...
Comment by Amigo11 on Oct 14, 2021 9:01am
Where did you read that ?
Comment by woundedknee on Oct 14, 2021 10:23am
It's indirectly written in the press release. This company is starting over again imo. gl
Comment by TriumphSpitSix on Oct 14, 2021 6:03pm
ATB-346 has been given to at least 700 people since 2014, the vast majority of whom did not experience elevated LTEs. Who is the "subset" with hypersensitive livers that ruined this trial? Why didn't this issue arise when we were dosing 250mg? If it's "dose dependent" we should have seen crazy LTEs at 250mg when it happened in people at 100mg and even one in the 75mg ...more  
Comment by Nick80 on Oct 14, 2021 6:23pm
Thats what I dont understand either I would like someone of antibe to take position to those findings... If they don't buy their stock to show their confiction than I don't know what could really bring some trust for investors... other than some magic which i suppose will take years  Imagine this elevation occuring on the shorter term for the 'acute pain' than either the ...more  
Comment by StockingUp21 on Oct 14, 2021 6:43pm
I agree with everything you say. But why did you stay invest here because there are certain people who disappear on these type of days that may or may not be paid by this company to say things to lead us on and take no responsibilty   
Comment by Nick80 on Oct 14, 2021 7:31pm
A good question, I have to answer myself every day since the unexpected findings of the AME study. Why did I not just take the profit or later on digestible loss and see how things pan out, for now I will monitor and sell my position if there is not any material news within the next 3 month justifying me holding the bag any longer...